Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Watch the Video

Recent News

09.08 2020
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
09.03 2020
Translate Bio to Participate in Upcoming Investor Conferences
08.06 2020
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
07.20 2020
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases

View All

@TranslateBio